Melexis (MELE) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
4 Feb, 2026Executive summary
Full year 2025 sales were EUR 839.6 million, down 10% year-over-year, with Q4 sales at EUR 214.5 million, up 9% year-over-year; net income for 2025 was EUR 112.5 million (EUR 2.78/share), down 34% year-over-year, with Q4 net income at EUR 22.6 million (EUR 0.56/share), up 24% year-over-year.
APAC, especially China, drove growth with record Q4 sales, while Europe and the Americas were weaker sequentially; automotive applications accounted for 88% of full-year sales.
Innovation included 90 new product launches in 2025, notably in automotive, robotics, and protective devices for power modules.
Strategic focus on China and India, with localization of supply chain, new teams, and an India entity being established to capture growth.
The company maintains a strong position in automotive sensors, ranking 4th globally, and continues to innovate in sensor and driver ICs.
Financial highlights
Full year 2025 sales were EUR 839.6 million, down 10% year-over-year; Q4 sales were EUR 214.5 million, up 9% year-over-year.
Gross margin for 2025 was 38.6%, down from 43.0% in 2024; Q4 gross margin was 38.4%.
Operating income for 2025 was EUR 134 million (16% margin), down 39% year-over-year; Q4 operating income was EUR 31.5 million (14.7% margin), up 14% year-over-year.
Net income for 2025 was EUR 112.5 million (EUR 2.78/share), down 34% year-over-year; Q4 net income was EUR 22.6 million (EUR 0.56/share), up 24% year-over-year.
Dividend payout for 2025 is EUR 3.7/share (EUR 2.4 final, EUR 1.3 interim).
Outlook and guidance
Sales in H1 2026 expected to be flat year-over-year; H2 2026 expected to grow versus H1.
Gross margin for H1 2026 expected around 40%; operating margin around 17% (EUR/USD 1.17 assumed).
CapEx for 2026 expected at EUR 40 million.
Price erosion expected at mid-single digits in 2026, offset by positive product mix.
Long-term high single-digit growth target remains intact.
Latest events from Melexis
- Accelerated innovation, market expansion, and robust financial targets drive future growth.MELE
CMD 20253 Feb 2026 - Q2 2024 sales up 4% year-over-year, with strong margins and lower CAPEX guidance.MELE
Q2 20242 Feb 2026 - Q3 sales steady at €247.9M, but full-year outlook cut amid inventory and market headwinds.MELE
Q3 202417 Jan 2026 - Q1 2025 sales dropped 18% year-over-year, with margins pressured and China strategy advancing.MELE
Q1 202524 Dec 2025 - 2024 sales and profits declined, but innovation and design wins support a mid-2025 recovery.MELE
Q4 202416 Dec 2025 - Q3 sales reached €215.3M, down 13% year-over-year, with gross margin at 38.8%.MELE
Q3 202529 Oct 2025 - Sequential sales and margin growth in Q2 2025, with full-year outlook reaffirmed.MELE
Q2 202530 Jul 2025